Clinical Trial

Short-term Effects of Broccoli-derived Glucoraphanin on Recovery From Eccentric Muscle Damage

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 28, 2026 (before its estimated March 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Eccentric exercise induces muscle damage and delay functional recovery. Broccoli-derived glucoraphanin (a sulforaphane precursor that activates Nrf2 defenses) may aid repair; however, its short-term effects in humans remains unknown. This study aims to evaluate whether short-term supplementation with broccoli-derived glucoraphanin will improve recovery from exercise-induced muscle damage. In a randomized, double-blind, placebo-controlled crossover design, fifteen participants will consume either high-glucoraphanin broccoli powder (320 μg) or placebo for one week, followed by elbow flexor eccentric exercise and continued supplementation. Strength, soreness, creatine kinase (CK), range of motion (ROM), arm girths, and ultrasound-assessed muscle and tendon morphology will be measured at baseline, immediately post-exercise, and at 48 and 96 hours post-exercise.
Trial Details
NCT Number NCT07373106
Lead Sponsor Lithuanian Sports University
Conditions Healthy
Enrollment 17 participants
Start Date 2026-02-15
Primary Completion 2026-03-15 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-28